glp 1 death rate GLP-1s may reduce mortality for people with sickle cell disease glp-1 colorectal cancer death risk

I thought you said in red blood cells

Microdosing GLP-1 for Autoimmune Conditions According to a comprehensive systematic review published in 2024, treatment with GLP-1 receptor agonists results in significant reductions in disease severity among patients with psoriasis

"For someone with type 2 diabetes or significant obesity, the cardiovascular, kidney and metabolic benefits [of these medications] are large and well-established, and stopping abruptly carries its own risks, so any change should be a conversation with your prescriber," he said

J.PooleC

Muni, MD MSc FRCSC, associate professor and vice chair of Clinical Research in the Department of Ophthalmology and Vision Sciences at the University of Toronto in Canada, and principal investigator of this study explained to Medical News Today